Intratumoral heterogeneity as a predictive biomarker in anti-PD-(L)1 therapies for non-small cell lung cancer.
作者信息
Fang Wenfeng, Jin Haoxuan, Zhou Huaqiang, Hong Shaodong, Ma Yuxiang, Zhang Yaxiong, Su Xiaofan, Chen Longyun, Yang Yunpeng, Xu Shengqiang, Liao Yuwei, He Yuming, Zhao Hongyun, Huang Yan, Gao Zhibo, Zhang Li
机构信息
Department of Medical Oncology, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China; Collaborative Innovation Center for Cancer Medicine; Guangzhou Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, 651 Dongfeng Road East, Guangzhou, 510060, Guangdong, China.
Cancer Research Institute of YuceBio, Shenzhen, China.
出版信息
Mol Cancer. 2021 Feb 23;20(1):37. doi: 10.1186/s12943-021-01331-9.
Abstract
摘要
Zotero 插件